EDGEWISE THERAPEUTICS
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Guided by its holistic drug discovery approach to targeting the muscle as an organ, Edgewise has combined its foundational expertise in muscle biology and small molecule engineering to build its proprietary, muscle focused drug discovery platform. Edgewise’s platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases.
EDGEWISE THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care
Founded:
2017-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.edgewisetx.com
Total Employee:
11+
Status:
Active
Contact:
720.262.7002
Total Funding:
160.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Arcutis Biotherapeutics
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
Current Advisors List
Board_member
Current Employees Featured
Kevin Koch CEO @ Edgewise Therapeutics
CEO
Alan Russell Co-Founder & Chief Scientific Officer @ Edgewise Therapeutics
Co-Founder & Chief Scientific Officer
2017-07-01
Joanne M. Donovan Chief Medical Officer @ Edgewise Therapeutics
Chief Medical Officer
R.Michael Carruthers Chief Financial Officer @ Edgewise Therapeutics
Chief Financial Officer
2020-09-01
Badreddin Edris Co-Founder @ Edgewise Therapeutics
Co-Founder
2018-03-01
Founder
Stock Details
Investors List
New Leaf Ventures
New Leaf Ventures investment in Series C - Edgewise Therapeutics
Viking Global Investors
Viking Global Investors investment in Series C - Edgewise Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Edgewise Therapeutics
OrbiMed
OrbiMed investment in Series C - Edgewise Therapeutics
U.S. Venture Partners
U.S. Venture Partners investment in Series C - Edgewise Therapeutics
Surveyor Capital
Surveyor Capital investment in Series C - Edgewise Therapeutics
CureDuchenne Ventures
CureDuchenne Ventures investment in Series C - Edgewise Therapeutics
Deerfield
Deerfield investment in Series C - Edgewise Therapeutics
Novo Holdings
Novo Holdings investment in Series C - Edgewise Therapeutics
Citadel
Citadel investment in Series C - Edgewise Therapeutics
Official Site Inspections
http://www.edgewisetx.com Semrush global rank: 5.05 M Semrush visits lastest month: 1.64 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Edgewise Therapeutics"
Company | Edgewise
Our Vision Our vision is to improve the lives of patients and families suffering from rare muscle disorders by building the world’s leading muscle-focused, precision medicine company.See details»
About Edgewise Therapeutics
Jul 29, 2024 Unique muscle diseases require a unique mindset. That’s why we built Edgewise differently. We seek to pursue lines of scientific inquiry around muscle pathology, starting with …See details»
Edgewise Therapeutics, Inc. - Investor Relations
Dec 16, 2024 ir@edgewisetx.com. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After …See details»
Edgewise Therapeutics - Crunchbase Company Profile …
Contact Email info@edgewisetx.com Phone Number 720.262.7002 Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for …See details»
Edgewise Corporate Overview, November 2024
Nov 15, 2024 ir@edgewisetx.com. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After …See details»
Edgewise Therapeutics - LinkedIn
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.See details»
Edgewise Therapeutics, Inc. (EWTX) - Yahoo Finance Canada
See the company profile for Edgewise Therapeutics, Inc. (EWTX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Edgewise Therapeutics, Inc. - Governance - Board of Directors
Craig McDonald, M.D. is a an internationally recognized expert in the clinical management, rehabilitation, and precision therapeutics for children and adults with muscle diseases.See details»
Edgewise Therapeutics, Inc. (EWTX) - Yahoo Finance
See the company profile for Edgewise Therapeutics, Inc. (EWTX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives ...See details»
Join Our Team | Edgewise
Join our Team. We know that for individuals with rare muscle disorders, every day without an effective treatment is a day too late. We are driven by this urgency to develop novel precision …See details»
Edgewise Therapeutics Overview | SignalHire Company Profile
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.See details»
Edgewise Therapeutics Provides Corporate Update and Highlights ...
5 days ago Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighteSee details»
Working at Edgewise Therapeutics - Zippia
Mar 14, 2024 edgewisetx.com. Organization Type. Public. Social Media. Edgewise Therapeutics is a new company harnessing proven expertise and understanding of skeletal muscle …See details»
How Does Edgewise Therapeutics Work? – CBM
[cbm_blg_rlnkng]Edgewise Therapeutics operates in the biopharmaceutical industry, utilizing innovative approaches to develop groundbreaking treatments for rare muscle disorders. The …See details»
Support for Duchenne Muscular Dystrophy Patients & Families
The organization also supports people and families with Becker. Learn More. Jett Foundation. Dedicated to funding Duchenne research and direct service programming for families …See details»
Edgewise Therapeutics | Boulder CO - Facebook
Edgewise Therapeutics, Boulder, Colorado. 290 likes · 33 talking about this. On a mission to improve the lives of people facing serious muscle disease.See details»
Edgewise Therapeutics, Inc. (EWTX) - Yahoo Finance
Find the latest Edgewise Therapeutics, Inc. (EWTX) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Privacy Policy - edgewisetx.com
Sep 11, 2024 contract research organization (the CRO) our business partners or other third parties; your employer or principal; to assess your suitability; to communicate with you; to …See details»
Event Details - investors.edgewisetx.com
Sep 19, 2024 Members of the Edgewise management team will hold a live webcast to discuss top-line data of EDG-7500 from the Phase 1 trial in healthy subjects and the single-dose arm …See details»
Terms of Use - Edgewise
Apr 12, 2023 The Site is offered by EDGEWISE Therapeutics, Inc. located at 1715 38th St., Boulder, Colorado 80301. You may contact us by sending correspondence to that address or …See details»